Bildkälla: Stockfoto

Herantis Pharma: Our H1 Comment - Redeye

Redeye comments on yesterday’s H1 report from Herantis and we reiterate our view of the company.

Redeye comments on yesterday’s H1 report from Herantis and we reiterate our view of the company.
Börsvärldens nyhetsbrev
ANNONSER